These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34777556)

  • 1. SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system.
    Khan T; Jamal SM
    Future Virol; 2021 Oct; ():. PubMed ID: 34777556
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent neutralization of SARS-CoV-2 including variants of concern by vaccines presenting the receptor-binding domain multivalently from nanoscaffolds.
    Halfmann PJ; Castro A; Loeffler K; Frey SJ; Chiba S; Kawaoka Y; Kane RS
    Bioeng Transl Med; 2021 Sep; 6(3):e10253. PubMed ID: 34589610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution.
    Devaux CA; Pinault L; Delerce J; Raoult D; Levasseur A; Frutos R
    Front Microbiol; 2021; 12():675528. PubMed ID: 34616371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: Coronavirus Vaccine Development Updates.
    Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
    Front Immunol; 2020; 11():602256. PubMed ID: 33424848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Concern and Interest SARS-CoV-2 Variants.
    Janik E; Niemcewicz M; Podogrocki M; Majsterek I; Bijak M
    Pathogens; 2021 May; 10(6):. PubMed ID: 34064143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
    Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy.
    Ramesh S; Govindarajulu M; Parise RS; Neel L; Shankar T; Patel S; Lowery P; Smith F; Dhanasekaran M; Moore T
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    J Proteome Res; 2020 Nov; 19(11):4355-4363. PubMed ID: 33006287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19.
    Ramos AM; Vela-Pérez M; Ferrández MR; Kubik AB; Ivorra B
    Commun Nonlinear Sci Numer Simul; 2021 Nov; 102():105937. PubMed ID: 34188432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.
    Hui DS; Zumla A; Tang JW
    Curr Opin Pulm Med; 2021 May; 27(3):146-154. PubMed ID: 33660619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?
    Vasireddy D; Vanaparthy R; Mohan G; Malayala SV; Atluri P
    J Clin Med Res; 2021 Jun; 13(6):317-325. PubMed ID: 34267839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?
    Guo S; Liu K; Zheng J
    Int J Biol Sci; 2021; 17(6):1476-1485. PubMed ID: 33907511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.
    To KK; Sridhar S; Chiu KH; Hung DL; Li X; Hung IF; Tam AR; Chung TW; Chan JF; Zhang AJ; Cheng VC; Yuen KY
    Emerg Microbes Infect; 2021 Dec; 10(1):507-535. PubMed ID: 33666147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic.
    Marshall NC; Kariyawasam RM; Zelyas N; Kanji JN; Diggle MA
    Virol J; 2021 May; 18(1):93. PubMed ID: 33933115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.
    Castonguay N; Zhang W; Langlois MA
    Front Microbiol; 2021; 12():676314. PubMed ID: 34267735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine efficacy in mutant SARS-CoV-2 variants.
    Kandikattu HK; Yadavalli CS; Venkateshaiah SU; Mishra A
    Int J Cell Biol Physiol; 2021; 4(1-2):1-12. PubMed ID: 34790972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.